Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol TIVA in Robot-assisted Gynecologic Surgery
NCT07251101Not yet recruiting
- Sponsor
- Ilsan CHA Hospital
- Start
- May 2026
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of remimazolam in Anesthesia (2 arms), sponsored by Ilsan CHA Hospital. Primary endpoint: Mean Arterial Pressure Time-Weighted Average up to 5 hours. Planned start May 2026; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Anesthesia
Beyond the preview
Go deeper on NCT07251101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07251101.